Statistics for Akoya Biosciences, (id:8161 AKYA)

Valuation metrics

Market cap

158.89M

Enterprise value

198.37M

Trailing P/E (ttm)

-1.48

Forward P/E

-5.84

PEG ratio

-5.84

Price/Sales (ttm)

1.70

Price/Book (mrq)

7.13

Enterprise Value/Revenue

2.13

Enterprise Value/EBITDA

-5.02

Overview

Shares outstanding

49.50M

Float

16.13M

Shares short

1.60M

% Held by insiders

0.11%

% Held by institutions

0.70%

Average volume (10 days)

122.26K

Average volume (90 days)

Price summary

52-Week low

1.88

52-Week high

6.31

52-Week change

-115.64%

Beta

1.35

50-Day moving average

2.87

200-Day moving average

3.37

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

-64.74%

Operating margin

-47.47%

Operational effectiveness

Return on assets

-18.09%

Return on equity

-128.20%

Income statement

Revenue (ttm)

1.89

Revenue per share (ttm)

1.89

Quarterly revenue growth (yoy)

Gross profit (ttm)

56.30M

EBITDA

-39,486,000.00

Net income to common (ttm)

-60,351,000.00

Diluted EPS (ttm)

-1.18

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

45.22M

Total cash per share (mrq)

0.91

Total debt (mrq)

84.70M

Total Debt/Equity (mrq)

380.68

Current ratio (mrq)

273.40%

Book value per share (mrq)

0.45

Cash flow

Cash flow statement

-51,202,000.00

Levered free cash flow (LFCF)

-34,914,376.00